Related Experiment Videos
Estrogens acting as cardiovascular agents: direct vascular actions
Alfred O Mueck1, Harald Seeger
1Section of Endocrinology and Menopause, University Women's Hospital, Tuebingen, Germany. endo.meno@med.uni-tuebingen.de
Current Medicinal Chemistry. Cardiovascular and Hematological Agents
|August 24, 2004
Summary
Estrogens offer significant vascular benefits by improving vasotonus and delaying atherosclerosis. However, the addition of progestins may counteract these positive effects, requiring further investigation.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Pharmacology
Background:
- Estrogens demonstrate beneficial effects on the vascular wall.
- Atherosclerosis is an inflammatory, fibroproliferative process.
- Estrogenic effects on vascular function are complex and influenced by co-administered hormones.
Purpose of the Study:
- To review recent literature and original studies on the vascular effects of estrogens.
- To elucidate the mechanisms by which estrogens influence vasotonus and atherogenesis.
- To investigate the impact of progestin addition on estrogenic vascular effects.
Main Methods:
- Literature review of in vitro and in vivo studies.
- Analysis of own experimental and clinical data.
- Examination of molecular mechanisms including gene expression and inflammatory markers.
Main Results:
- Estrogens positively affect vasotonus by modulating nitric oxide, prostacyclin, endothelin, and calcium channels.
- Estrogens delay atherogenesis by downregulating inflammatory markers, inhibiting smooth muscle cell proliferation, and possessing antioxidative properties.
- Estrogens stabilize atherosclerotic plaques and reduce thrombogenic potential, while progestins can exhibit antagonistic effects.
Conclusions:
- Estrogens provide multifaceted vascular protection, impacting vasotonus, atherogenesis, plaque stability, and thrombogenicity.
- Progestin co-administration can modify estrogenic vascular benefits, with effects varying by progestin type and administration.
- Further research is needed to fully understand the role and optimal use of progestins in conjunction with estrogen therapy for vascular health.